SEARCH

SEARCH BY CITATION

References

  • Cheitlin MD, Hutter AM, Jr, Brindis RG, Ganz P, Kaul S, Russell RO, Jr et al. (1999). ACC/AHA expert consensus document. Use of sildenafil (Viagra) in patients with cardiovascular disease. American College of Cardiology/American Heart Association. J Am Coll Cardiol 33: 273282.
  • Das A, Xi L, Kukreja RC (2008). Protein kinase G-dependent cardioprotective mechanism of phosphodiesterase-5 inhibition involves phosphorylation of ERK and GSK3beta. J Biol Chem 283: 2957229585.
  • Davies CH, Davia K, Bennett JG, Pepper JR, Poole-Wilson PA, Harding SE (1995). Reduced contraction and altered frequency response of isolated ventricular myocytes from patients with heart failure. Circulation 92: 25402549.
  • Foster FS, Mehi J, Lukacs M, Hirson D, White C, Chaggares C et al. (2009). A new 15-50 MHz array-based micro-ultrasound scanner for preclinical imaging. Ultrasound Med Biol 35: 17001708.
  • George I, Mekahli D, Rayyan M, Levtchenko E, Allegaert K (2011a). Postnatal trends in creatinemia and its covariates in extremely low birth weight (ELBW) neonates. Pediatr Nephrol 26: 18431849.
  • George I, Sabbah HN, Xu K, Wang N, Wang J (2011b). beta-adrenergic receptor blockade reduces endoplasmic reticulum stress and normalizes calcium handling in a coronary embolization model of heart failure in canines. Cardiovasc Res 91: 447455.
  • Hiroi T, Wei H, Hough C, Leeds P, Chuang DM (2005). Protracted lithium treatment protects against the ER stress elicited by thapsigargin in rat PC12 cells: roles of intracellular calcium, GRP78 and Bcl-2. Pharmacogenomics J 5: 102111.
  • Hsu S, Nagayama T, Koitabashi N, Zhang M, Zhou L, Bedja D et al. (2009). Phosphodiesterase 5 inhibition blocks pressure overload-induced cardiac hypertrophy independent of the calcineurin pathway. Cardiovasc Res 81: 301309.
  • Hu MC, Gong HY, Lin GH, Hu SY, Chen MH, Huang SJ et al. (2007). XBP-1, a key regulator of unfolded protein response, activates transcription of IGF1 and Akt phosphorylation in zebrafish embryonic cell line. Biochem Biophys Res Commun 359: 778783.
  • Ikeda Y, Gohra H, Hamano K, Zempo N, Ueyama T, Ohkusa T et al. (2001). Effects of cardioplegic arrest and reperfusion on rabbit cardiac ryanodine receptors. Jpn Circ J 65: 330334.
  • Jiang CC, Wroblewski D, Yang F, Hersey P, Zhang XD (2009). Human melanoma cells under endoplasmic reticulum stress are more susceptible to apoptosis induced by the BH3 mimetic obatoclax. Neoplasia 11: 945955.
  • Kaufman RJ (2002). Orchestrating the unfolded protein response in health and disease. J Clin Invest 110: 13891398.
  • Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG (2010). Animal research: Reporting in vivo experiments: The ARRIVE guidelines. Br J Pharmacol 160: 15771579.
  • Koka S, Kukreja RC (2010). Attenuation of Doxorubicin-induced cardiotoxicity by tadalafil: a long acting phosphodiesterase-5 inhibitor. Mol Cell Pharmacol 2: 173178.
  • Lu Z, Xu X, Hu X, Lee S, Traverse JH, Zhu G et al. (2010). Oxidative stress regulates left ventricular PDE5 expression in the failing heart. Circulation 121: 14741483.
  • Maltsev VA, Sabbah HN, Tanimura M, Lesch M, Goldstein S, Undrovinas AI (1998). Relationship between action potential, contraction-relaxation pattern, and intracellular Ca2+ transient in cardiomyocytes of dogs with chronic heart failure. Cell Mol Life Sci 54: 597605.
  • Mattson MP, Chan SL (2003). Calcium orchestrates apoptosis. Nat Cell Biol 5: 10411043.
  • McGrath J, Drummond G, Kilkenny C, Wainwright C (2010). Guidelines for reporting experiments involving animals: the ARRIVE guidelines. Br J Pharmacol 160: 15731576.
  • Minamino T, Kitakaze M (2010). ER stress in cardiovascular disease. J Mol Cell Cardiol 48: 11051110.
  • Mudd JO, Kass DA (2008). Tackling heart failure in the twenty-first century. Nature 451: 919928.
  • Myoishi M, Hao H, Minamino T, Watanabe K, Nishihira K, Hatakeyama K et al. (2007). Increased endoplasmic reticulum stress in atherosclerotic plaques associated with acute coronary syndrome. Circulation 116: 12261233.
  • Nagayama T, Hsu S, Zhang M, Koitabashi N, Bedja D, Gabrielson KL et al. (2009). Sildenafil stops progressive chamber, cellular, and molecular remodeling and improves calcium handling and function in hearts with pre-existing advanced hypertrophy caused by pressure overload. J Am Coll Cardiol 53: 207215.
  • Nagendran J, Archer SL, Soliman D, Gurtu V, Moudgil R, Haromy A et al. (2007). Phosphodiesterase type 5 is highly expressed in the hypertrophied human right ventricle, and acute inhibition of phosphodiesterase type 5 improves contractility. Circulation 116: 238248.
  • Ni L, Zhou C, Duan Q, Lv J, Fu X, Xia Y et al. (2011). β-AR blockers suppresses ER stress in cardiac hypertrophy and heart failure. Plos ONE 6: e27294.
  • Nienaber JJ, Tachibana H, Naga Prasad SV, Esposito G, Wu D, Mao L et al. (2003). Inhibition of receptor-localized PI3K preserves cardiac beta-adrenergic receptor function and ameliorates pressure overload heart failure. J Clin Invest 112: 10671079.
  • Okada K, Minamino T, Tsukamoto Y, Liao Y, Tsukamoto O, Takashima S et al. (2004). Prolonged endoplasmic reticulum stress in hypertrophic and failing heart after aortic constriction: possible contribution of endoplasmic reticulum stress to cardiac myocyte apoptosis. Circulation 110: 705712.
  • Oyadomari S, Araki E, Mori M (2002). Endoplasmic reticulum stress-mediated apoptosis in pancreatic beta-cells. Apoptosis 7: 335345.
  • Perez NG, Piaggio MR, Ennis IL, Garciarena CD, Morales C, Escudero EM et al. (2007). Phosphodiesterase 5A inhibition induces Na+/H+ exchanger blockade and protection against myocardial infarction. Hypertension 49: 10951103.
  • Pokreisz P, Vandenwijngaert S, Bito V, Van den Bergh A, Lenaerts I, Busch C et al. (2009). Ventricular phosphodiesterase-5 expression is increased in patients with advanced heart failure and contributes to adverse ventricular remodeling after myocardial infarction in mice. Circulation 119: 408416.
  • Schroder M, Kaufman RJ (2005). The mammalian unfolded protein response. Annu Rev Biochem 74: 739789.
  • Szegezdi E, Duffy A, O'Mahoney ME, Logue SE, Mylotte LA, O'Brien T et al. (2006a). ER stress contributes to ischemia-induced cardiomyocyte apoptosis. Biochem Biophys Res Commun 349: 14061411.
  • Szegezdi E, Logue SE, Gorman AM, Samali A (2006b). Mediators of endoplasmic reticulum stress-induced apoptosis. EMBO Rep 7: 880885.
  • Takimoto E, Champion HC, Li M, Belardi D, Ren S, Rodriguez ER et al. (2005). Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy. Nat Med 11: 214222.
  • Urano F, Wang X, Bertolotti A, Zhang Y, Chung P, Harding HP et al. (2000). Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. Science 287: 664666.
  • Wang H, Lin L, Jiang J, Wang Y, Lu ZY, Bradbury JA et al. (2003). Up-regulation of endothelial nitric-oxide synthase by endothelium-derived hyperpolarizing factor involves mitogen-activated protein kinase and protein kinase C signaling pathways. J Pharmacol Exp Ther 307: 753764.
  • Zhang K, Kaufman RJ (2008). From endoplasmic-reticulum stress to the inflammatory response. Nature 454: 455462.